Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2545PDF: 1047HTML: 99 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1109PDF: 582HTML: 6783 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1352PDF: 645HTML: 1364cover letter: 188 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1200PDF: 452HTML: 18542Figure 1: 154Figure 2: 138Figure 3: 154Figure 4: 187Figure 5: 157 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2205PDF: 1296HTML: 17058Bassan Fig.1: 133Bassan Fig.2: 129Bassan Fig.4: 126Fig.3: 164 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2516PDF: 775HTML: 5175 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1336PDF: 797HTML: 3103 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1228PDF: 1140HTML: 422 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4561PDF: 1281HTML: 1887Untitled: 165Untitled: 162 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1973PDF: 1460HTML: 259 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2075PDF: 1524HTML: 248 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1229PDF: 587HTML: 3058 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1906PDF: 789HTML: 2187Table 1: 158Table 2: 173Table 3: 169Table 4: 174Table 5: 171Tble 6: 164Cover Letter: 185Greene Tab.7: 169 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3229PDF: 1430HTML: 3975 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1170PDF: 448HTML: 129 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1866PDF: 1053HTML: 567 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1447PDF: 1132HTML: 171 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3500PDF: 834HTML: 6695 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4538PDF: 2731HTML: 2245







